处于商业化阶段的生物技术公司英派药业-B (07630.HK)今日(5日)起至本周五(8日)招股,计划发行4197.7万股H股,一成于香港作公开发售,每股招股价介乎19.75元至21.75元,集资最多9.1亿元,每手200股,一手入场费4393.9元。预期将于5月13日挂牌买卖,高盛、中金公司为联席保荐人。英派药业成立于2009年,致力推进基于合成致死(synthetic lethality)机制...
Source Link处于商业化阶段的生物技术公司英派药业-B (07630.HK)今日(5日)起至本周五(8日)招股,计划发行4197.7万股H股,一成于香港作公开发售,每股招股价介乎19.75元至21.75元,集资最多9.1亿元,每手200股,一手入场费4393.9元。预期将于5月13日挂牌买卖,高盛、中金公司为联席保荐人。英派药业成立于2009年,致力推进基于合成致死(synthetic lethality)机制...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.